All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Cost–Benefit Analysis in Health Care: the Case of Bariatric Surgery Compared With Diet

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F20%3A00337416" target="_blank" >RIV/68407700:21460/20:00337416 - isvavai.cz</a>

  • Result on the web

    <a href="https://doi.org/10.1016/j.clinthera.2019.12.001" target="_blank" >https://doi.org/10.1016/j.clinthera.2019.12.001</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.clinthera.2019.12.001" target="_blank" >10.1016/j.clinthera.2019.12.001</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Cost–Benefit Analysis in Health Care: the Case of Bariatric Surgery Compared With Diet

  • Original language description

    The aim of the present study was to assess, by using a cost–benefit analysis, the net monetary benefit (NMB) of bariatric surgery compared with diet (including physical exercise) for obese patients, from both an Italian payer perspective and the broader societal perspective. The study considered the following groups of patients: (1) patients with a body mass index (BMI) >=40 kg/m2 without complications + patients with BMI >=35 kg/m2 with complications; (2) patients with BMI >=35 kg/m2 and diabetes; and (3) patients with BMI ranging from 30 to 35 kg/m2 and diabetes. A Markov model was developed to project the lifetime health outcomes (life years and quality-adjusted life years [QALYs]) and costs associated with bariatric surgery and diet for the considered groups of patients. The clinical effectiveness of each strategy was based on the likelihood of experiencing cardiovascular events or events related to the presence of diabetes. Data on clinical effectiveness, quality of life, productivity losses, and out-of-pocket costs were mainly derived from the literature; direct costs were obtained from official tariffs or the literature. Different scenarios were considered for the analyses in addition to the base case. According to both perspectives considered, the NMB was calculated by first assuming a willingness-to-pay threshold (30,000 per QALY), then converting health benefits (QALYs) into the common monetary metric (ie, the euro). NMB was calculated as follows: (incremental benefit x willingness-to-pay – incremental cost).

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30304 - Public and environmental health

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Clinical Therapeutics

  • ISSN

    0149-2918

  • e-ISSN

    1879-114X

  • Volume of the periodical

    42

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    23

  • Pages from-to

    "60"-"75.e7"

  • UT code for WoS article

    000516654800008

  • EID of the result in the Scopus database

    2-s2.0-85078022563